FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/18/2022
Back to search
Official data from USPTO
EVIVE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EVIVE
ST13
US500000079295058Class
5, 10, 42
Filing
79295058
Registration
6488611
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
04/18/2022
Trademark type
Word
Nice classes
5, 10, 42
Filing date
07/08/2020
Registration date
09/21/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/21/2021
Last transaction
09/21/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
SG
Examiner
STIGLITZ, SUSAN
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
EVIVE BIOTECHNOLOGY SINGAPORE PTE. LTD.
SCIGEN PTE. LTD.
Representatives
Lisa W. Rosaya Baker & McKenzie LLP
Technical classification
Nice Classes
Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticalsmedical and veterinary preparationspreparations for the treatment of infectious disease and for use in oncologydiagnostic preparations for medical purposes for detecting the presence of malignantinflammatory and autoimmune disorders and conditions and tissue trauma in humanspharmaceutical preparations for use in chemotherapypharmaceutical products for the prevention and treatment of cancerpharmaceutical preparations for the treatment of viral infections and diseasesantibacterial pharmaceuticals; pharmaceutical preparations for health careanti-inflammatory preparationsantipyretic preparationsbiological preparations for the treatment of cancermixed biological preparations for the treatment and prevention of infectious diseases
Class 10
Apparatus for medical useinsulin pumpsinsulin injectors sold emptymedical fluid injectors
Class 42
Research and development services relating to medicines; medical laboratory services; medical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; design of medical apparatus for others; biotechnology research; research relating to pharmaceuticals
Publications
History of USPTO decisions and trademark events.
28 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
03/07/2022
XXCR
GENERIC MADRID TRANSACTION CREATED
03/07/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/21/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
09/21/2021
GPNX
NOTIFICATION PROCESSED BY IB
07/19/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/06/2021
PUBO
PUBLISHED FOR OPPOSITION
07/06/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/30/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/30/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/16/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/28/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/12/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/11/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/11/2021
ATRV
ATTORNEY REVIEW COMPLETED
03/25/2021
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
03/25/2021
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
03/20/2021
CHLD
CHANGE OF OWNER RECEIVED FROM IB
03/05/2021
RFNT
REFUSAL PROCESSED BY IB
12/06/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/11/2020
RFRR
REFUSAL PROCESSED BY MPU
11/11/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/21/2020
CNRT
NON-FINAL ACTION WRITTEN
10/20/2020
DOCK
ASSIGNED TO EXAMINER
10/19/2020
MAFR
APPLICATION FILING RECEIPT MAILED
10/17/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/13/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/08/2020
Continuous trademark protection
Get notified about every new filing that threatens EVIVE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.